Modified vaccinia virus Ankara undergoes limited replication in human cells and lacks several immunomodulatory proteins: Implications for use as a human vaccine

Journal of General Virology

Volumn 79, Issue 5, 1998, Pages 1159-1167

  Blanchard, Tom J ^a   Alcamí, Antonio ^a   Andrea, Panayiota ^a   Smith, Geoffrey L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; INTERLEUKIN 1 RECEPTOR; SMALLPOX VACCINE;

ARTICLE; GENE DELETION; HUMAN; HUMAN CELL; IMMUNOGENICITY; INTERFERON INDUCTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS GENE; VIRUS REPLICATION;

ANIMALIA; ANKARA; DNA VIRUSES; MAMMALIA; VACCINIA; VACCINIA VIRUS; VARIOLA VIRUS;

EID: 0031899907     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-79-5-1159     Document Type: Article

References (41)

1. Aguado, B., Selmes, I. P. & Smith, G. L. (1992). Nucleotide sequence of 21·8 kbp of variola major virus strain Harvey and comparison with vaccinia virus. Journal of General Virology 73, 2887-2902.
2. Alcamí, A. & Smith, G. L. (1992). A soluble receptor for interleukin-1β encoded by vaccinia virus: a novel mechanism of virus modulation of the host response to infection. Cell 71, 153-167.
3. Alcamí, A. & Smith, G. L. (1995). Vaccinia, cowpox and camelpox viruses encode soluble interferon-γ receptors with novel broad species specificity. Journal of Virology 69, 4633-4639.
4. Alcamí, A. & Smith, G. L. (1996). A mechanism for the inhibition of fever by a virus. Proceedings of the National Academy of Sciences, USA 93, 11029-11034.
5. Alcamí, A., Symons, J. A., Collins, P. D., Williams, T. J. & Smith, G. L. (1998). Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. Journal of Immunology 160, 624-633.
6. Altenburger, W., Suter, C.-P. & Altenburger, J. (1989). Partial deletion of the human host range gene in the attenuated vaccinia virus MVA. Archives of Virology 105, 15-27.
7. Carroll, M. W., Overwijk, W. W., Chamberlain, R. S., Rosenberg, S. A., Moss, B. & Restifo, N. P. (1997). Highly attenuated modified vaccinia virus Ankara (MVA) as an effective recombinant vector: a murine tumor model. Vaccine 15, 387-394.
8. Colamonici, O. R., Domanski, P., Sweitzer, S. M., Larner, A. & Buller, R. M. L. (1995). Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. Journal of Biological Chemistry 270, 15974-15978.
9. Fenner, F., Anderson, D. A., Arita, I., Jezek, Z. & Ladnyi, I. D. (1988). Smallpox and its Eradication. Geneva: World Health Organization.
10. Graham, K. A., Lalani, A. S., Macen, J. L., Ness, T. L., Barry, M., Liu, L., Lucas, A., Clark-Lewis, I., Moyer, R. W. & McFadden, G. (1997). The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. Virology 229, 12-24.
11. Hirsch, V. M., Fuerst, T. R., Sutter, G., Carroll, M. W., Yang, L. C., Goldstein, S., Piatak, M., Jr, Elkins, W. R., Alvord, W. G., Montefiori, D. C., Moss, B. & Lifson, J. D. (1996). Patterns of viral replication correlate with outcome in simian immunodeficiency virus (SIV)-infected macaques: effect of prior immunization with a trivalent SIV vaccine in modified vaccinia virus Ankara. Journal of Virology 70, 3741-3752.
12. Hirsch, V. M., Goldstein, S., Chanock, R., Elkins, W. R., Sutter, G., Moss, B., Sisler, J., Lifson, J. & Fuerst, T. (1995). Limited virus replication following SIV challenge of macaques immunized with attenuated MVA vaccinia expressing SIV sm env and gag-pol. In Vaccines 95, pp. 195-200. Edited by R. Chanock. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
13. Hochstein-Mintzel, V., Huber, H. C. & Stickl, H. (1972). Virulenz und Immunogenität eines modifizierten Vaccinia-Virus (Stamm MVA). Immunitätsforschung und Experimentelle Klinische Immunologie 144, 140-145.
14. Howard, S. T., Chan, Y. S. & Smith, G. L. (1991). Vaccinia virus homologues of the Shope fibroma virus inverted terminal repeat proteins and a discontinuous ORF related to the tumour necrosis factor receptor family. Virology 180, 633-647.
15. Hu, F.-Q., Smith, C. A. & Pickup, D. J. (1994). Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. Virology 204, 343-356.
16. Lalani, A. S., Graham, K., Mossman, K., Rajarathnam, K., Clark-Lewis, I., Kelvin, D. & McFadden, G. (1997). The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines. Journal of Virology 71, 4356-4363.
17. Mahnel, H. & Mayr, A. (1994). Experiences with immunization against orthopox viruses of humans and animals using vaccine strain MVA. Berliner und Münchener Tierarztliche Wochenschrift 107, 253-256.
18. Mayr, A. (1976). TC marker of the attenuated vaccinia vaccine strain "MVA" in human cell cultures and protective immunization against orthopox diseases in animals. TC-Marker des attenuierten Vaccinia-Impfstammes "MVA" in menschlichen Zellkulturen. Zugleich ein Beitrag zur Schutzimpfung gegen Orthopox-Erkrankungen beim Tier. Zentralblatt für Veterinärmedizin B 23, 417-430.
19. Mayr, A., Hochstein-Mintzel, V. & Stickl, H. (1975). Abstammung, eigenschaftenund Verwendung des attenuierten Vaccinia-Stammes MVA. Infection 3, 6-16.
20. Mayr, A., Stickl, H., Muller, H. K., Danner, K. & Singer, H. (1978). The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl.). Zentralblatt für Bakteriologie und Hygiene B 167, 375-390.
21. Meyer, H., Sutter, G. & Mayr, A. (1991). Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence. Journal of General Virology 72, 1031-1038.
22. Moss, B., Carroll, M. W., Wyatt, L. S., Bennink, J, R., Hirsch, V. M., Goldstein, S., Elkins, W. R., Fuerst, T. R., Lifson, J. D., Piatak, M., Restifo, N. P., Overwijk, W., Chamberlain, R., Rosenberg, S. A. & Sutter, G. (1996). Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates. Advances in Experimental Medicine and Biology 397, 7-13.
23. Mossman, K., Upton, C., Buller, R. M. & McFadden, G. (1995). Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology 208, 762-769.
24. Mossman, K., Nation, P., Macen, J., Garbutt, M., Lucas, A. & McFadden, G. (1996). Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits. Virology 215, 17-30.
25. Munz, E., Linckh, S., Renner Muller, I. C. & Reimann, M. (1993). The effectiveness of immunization with vaccinia virus type "MVA" against an infection with cowpox virus type "OPV 85" in rabbits. Zentralblatt für Veterinärmedizin B 40, 131-140.
26. Plebanski, M., Elson, C. J. & Billington, W. D. (1992). Dependency on interleukin-1 of primary human in vitro T cell responses to soluble antigens. European Journal of Immunology 22, 2353-2358.
27. Smith, C. A., Davis, T., Anderson, D., Solam, L., Beckmann, M. P., Jerzy, R., Dower, S. K., Cosman, D. & Goodwin, R. G. (1990). A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248, 1019-1023.
28. Smith, G. L., Chan, Y. S. & Howard, S. T. (1991). Nucleotide sequence of 42 kbp of vaccinia virus strain WR from near the right inverted terminal repeat. Journal of General Virology 72, 1349-1376.
29. Smith, C. A., Hu, F. Q., Smith, T. D., Richards, C. L., Smolak, P., Goodwin, R. G. & Pickup, D. J. (1996). Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 223, 132-147.
30. Smith, C. A., Smith, T. D., Smolak, P. J., Friend, D., Hagen, H., Gernart, M., Park, L., Pickup, D. J., Torrance, D., Mohler, K., Schooley, K. & Goodwin, R. G. (1997). Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology 236, 316-327.
31. Smith, G. L., Symons, J. A., Khanna, A., Vanderplasschen, A. & Alcamí, A. (1997). Vaccinia virus immune evasion. Immunological Reviews 159, 137-154.
32. Spriggs, M., Hruby, D. E., Maliszewski, C. R., Pickup, D. J., Sims, J. E., Buller, R. M. L. & Vanslyke, J. (1992). Vaccinia and cowpox viruses encode a novel secreted interleukin-1 binding protein. Cell 71, 145-152.
33. Stickl, H., Hochstein Mintzel, V., Mayr, A., Huber, H. C., Schafer, H. & Holzner, A. (1974). MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl.). Deutsche Medizinische Wochenschrift 99, 2386-2392.
34. Sutler, G. & Moss, B. (1992). Nonreplicating vaccinia vector efficiently expresses recombinant genes. Proceedings of the National Academy of Sciences, USA 89, 10847-10851.
35. Sutter, G., Ramsey Ewing, A., Rosales, R. & Moss, B. (1994a). Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant. Journal of Virology 68, 4109-4116.
36. Sutter, G., Wyatt, L. S., Foley, P. L., Bennink, J. R. & Moss, B. (1994b). A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus. Vaccine 12, 1032-1040.
37. Symons, J. A., Alcamí, A. & Smith, G. L. (1995). Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81, 551-560.
38. Tough, D. F., Borrow, P. & Sprent, J. (1996). Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950.
39. Tsung, K., Yim, J. H., Marti, W., Buller, R. M. L. & Norton, J. A. (1996). Gene expression and cytopathic effect of vaccinia virus inactivated by psoralen and long-wave UV light. Journal of Virology 70, 165-171.
40. Upton, C., Macen, J. L., Schreiber, M. & McFadden, G. (1991). Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370-382.
41. Wyatt, L. S., Moss, B. & Rozenblatt, S. (1995). Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells. Virology 210, 202-205.